Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05171829
NCT05171829UnknownNot Applicable

An Educational Self-tracking Tool for Identification of SARS-CoV-2 Risk Transmission: a Randomised Controlled Trial

Hospital Clinic of Barcelona2 sites in 1 country180 target enrollmentStarted: December 27, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
180
Locations
2
Primary Endpoint
Risk identification of SARS-CoV 2 transmission
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

One way to empower a community, in epidemic control issues, is to know the first-hand screening tools. There are no evaluations of these home-use tools from the perspective of patient and citizen empowerment and participation. The main objective of this study is to analyze whether a self-tracking and self-tracing tool, developed in a participatory way, increases the risk identification of the disease and the empowerment in terms of risk management of transmission by the participants.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Masking Description

Statistician masking

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Fluent in Catalan or Spanish, Resident in Catalonia, Signs informed consent, Commitment to use the tool if he/she gets in intervention group.

Exclusion Criteria

  • •Language barrier and other conditions that do not allow self-completion of the survey Be a COVID case or contact at the time of recruitment.

Outcomes

Primary Outcomes

Risk identification of SARS-CoV 2 transmission

Time Frame: 17 days

Risk identification of SARS-CoV 2 transmission

Secondary Outcomes

  • Empowerment in SARS-CoV 2 transmission(17 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Anna Llupia

Public Health Specialist

Hospital Clinic of Barcelona

Study Sites (2)

Loading locations...

Similar Trials

Completed
Not Applicable
Primary care screening to identify symptomatic menopausal womePrimary care screening to identify symptomatic menopausal womenNutritional, Metabolic, Endocrine
ISRCTN13287757Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)63
Completed
Not Applicable
Prevention and Early Identification for High Risk Youth in School-based ClinicsCommunity Mental Health ServicesAdolescent Well BeingResilience, PsychologicalHealth EquityScreening
NCT04935710Cambridge Health Alliance39
Unknown
Not Applicable
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic CommunicationFirst Episode Psychosis (FEP)Clinical High Risk for Psychosis (CHR)
NCT05509998Icahn School of Medicine at Mount Sinai912
Completed
Not Applicable
Facilitating the effective and early identification of children at risk for developing serious behavioral and emotional problemsgedrags en emotionele problemenBehavioral and emotional problems
NL-OMON44928Erasmus Universiteit Rotterdam1,330
Recruiting
Not Applicable
Development and Application of Comprehensive Intervention Techniques for Adolescent DepressionDepressive DisorderAdolescent
NCT05945342First Affiliated Hospital of Zhejiang University100
An Educational Self-tracking Tool for... | Clinical Trial